Clinical Trial Update: DX-8951f in Treating Patients With Metastatic Stomach Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on DX-8951f for metastatic gastric cancer and esophageal cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• DX-8951f

Snippet

Sponsor: Daiichi Sankyo | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED